Results 101 to 110 of about 1,596 (158)

Consensus statement on enzyme replacement therapy for mucopolysaccharidosis IVA in Central and South-Eastern European countries. [PDF]

open access: yesOrphanet J Rare Dis, 2022
Magner M   +8 more
europepmc   +1 more source

Sex Difference Leads to Differential Gene Expression Patterns and Therapeutic Efficacy in Mucopolysaccharidosis IVA Murine Model Receiving AAV8 Gene Therapy. [PDF]

open access: yesInt J Mol Sci, 2022
Piechnik M   +11 more
europepmc   +1 more source

EHA2024 Hybrid Congress

open access: yes
HemaSphere, Volume 8, Issue S1, June 2024.
wiley   +1 more source

Clinical features and health-related quality of life in adult patients with mucopolysaccharidosis IVA: the Spanish experience. [PDF]

open access: yesOrphanet J Rare Dis, 2021
Quijada-Fraile P   +15 more
europepmc   +1 more source

Heart and Cardiovascular Involvement in Patients with Mucopolysaccharidosis Type IVA (Morquio-A Syndrome).

open access: yes, 2016
Mucopolysaccharidosis (MPS) IVA is a rare lysosomal storage disorder with multiple skeletal and non-skeletal abnormalities requiring multiple surgical interventions.
Seyfullah Gökce   +7 more
core   +1 more source

Molecular basis of mucopolysaccharidosis IVA (Morquio A syndrome): A review and classification of GALNS gene variants and reporting of 68 novel variants. [PDF]

open access: yesHum Mutat, 2021
Zanetti A   +17 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy